IL-6

Interleukin-6 (IL-6) is a multifunctional cytokine involved in the regulation of immune responses, inflammation, and hematopoiesis. It is produced by various cell types, including leukocytes, adipocytes, and endothelial cells, and plays a critical role in the body's defense mechanisms. IL-6 is a key mediator in the acute phase response, stimulating the production of acute-phase proteins such as C-reactive protein (CRP) in the liver. Clinically, IL-6 is a significant biomarker for inflammatory conditions and has been implicated in the pathophysiology of cardiovascular diseases, including atherosclerosis and cardiogenic shock. Elevated IL-6 levels are associated with increased risk of atherothrombotic events and poor outcomes in conditions like acute myocardial infarction and heart failure. In the context of athletic performance and biohacking, IL-6 is of interest due to its dual role in inflammation and muscle repair. While acute increases in IL-6 post-exercise can promote muscle adaptation and repair, chronically elevated levels may indicate overtraining or systemic inflammation, potentially impacting recovery and performance. Researchers have observed that IL-6 levels can be influenced by factors such as age, time of day, and underlying health conditions. Diurnal variations and the presence of respiratory dysfunction, as seen in diseases like amyotrophic lateral sclerosis, can affect IL-6 measurements. Therefore, it is crucial to consider these confounders when interpreting IL-6 levels in clinical and performance settings.